- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/11 | 1.45 | 40.84 | 11.11 | 12.62 | 2.3 | 3.61 | N/A | - | ||
| 2024/10 | 1.03 | -9.25 | -10.97 | 11.17 | 1.26 | 3.14 | N/A | - | ||
| 2024/9 | 1.13 | 15.59 | 14.99 | 10.14 | 2.69 | 3.17 | 0.0 | - | ||
| 2024/8 | 0.98 | -6.67 | -2.53 | 9.01 | 1.33 | 3.18 | 0.0 | - | ||
| 2024/7 | 1.05 | -8.23 | 11.63 | 8.03 | 1.83 | 3.22 | 0.0 | - | ||
| 2024/6 | 1.15 | 12.01 | 16.56 | 6.98 | 0.5 | 3.16 | 0.0 | - | ||
| 2024/5 | 1.02 | 2.84 | -1.37 | 5.83 | -2.14 | 3.04 | 0.0 | - | ||
| 2024/4 | 0.99 | -2.62 | -10.25 | 4.81 | -2.31 | 3.51 | 0.0 | - | ||
| 2024/3 | 1.02 | -31.75 | -7.56 | 3.82 | 0.0 | 3.82 | 0.0 | - | ||
| 2024/2 | 1.5 | 15.31 | 24.46 | 2.79 | 3.07 | 4.13 | 0.0 | - | ||
| 2024/1 | 1.3 | -2.97 | -13.96 | 1.3 | -13.96 | 3.94 | 0.0 | - | ||
| 2023/12 | 1.34 | 2.53 | 8.59 | 13.68 | -13.66 | 3.8 | 0.0 | - | ||
| 2023/11 | 1.3 | 12.83 | 4.21 | 12.34 | -15.54 | 3.45 | 0.0 | - | ||
| 2023/10 | 1.16 | 17.21 | -3.15 | 11.03 | -17.39 | 3.15 | 0.0 | - | ||
| 2023/9 | 0.99 | -2.02 | -25.43 | 9.88 | -18.79 | 2.93 | 0.0 | - | ||
| 2023/8 | 1.01 | 6.9 | -19.24 | 8.89 | -17.98 | 2.93 | 0.0 | - | ||
| 2023/7 | 0.94 | -4.18 | -24.23 | 7.88 | -17.82 | 2.96 | 0.0 | - | ||
| 2023/6 | 0.98 | -5.21 | -22.55 | 6.94 | -16.86 | 3.13 | 0.0 | - | ||
| 2023/5 | 1.04 | -6.41 | -36.54 | 5.96 | -15.84 | 3.25 | 0.0 | - | ||
| 2023/4 | 1.11 | 0.3 | -18.81 | 4.92 | -9.64 | 3.42 | 0.0 | - | ||
| 2023/3 | 1.1 | -8.11 | -8.56 | 3.82 | -6.57 | 3.82 | 0.0 | - | ||
| 2023/2 | 1.2 | -20.28 | -6.24 | 2.71 | -5.74 | 3.94 | 0.0 | - | ||
| 2023/1 | 1.51 | 22.46 | -5.34 | 1.51 | -5.34 | 3.99 | 0.0 | - | ||
| 2022/12 | 1.23 | -1.6 | 1.83 | 15.84 | -6.57 | 3.68 | 0.0 | - | ||
| 2022/11 | 1.25 | 4.86 | -19.91 | 14.61 | -7.21 | 3.77 | 0.0 | - | ||
| 2022/10 | 1.19 | -9.75 | 3.91 | 13.36 | -5.81 | 3.76 | 0.0 | - | ||
| 2022/9 | 1.32 | 6.11 | -4.26 | 12.16 | -6.67 | 3.81 | 0.0 | - | ||
| 2022/8 | 1.25 | 0.29 | -18.7 | 10.84 | -6.96 | 3.76 | 0.0 | - | ||
| 2022/7 | 1.24 | -2.06 | -31.11 | 9.6 | -5.18 | 4.15 | 0.0 | - | ||
| 2022/6 | 1.27 | -22.33 | -31.12 | 8.35 | 0.44 | 4.27 | 0.0 | - | ||
| 2022/5 | 1.63 | 19.72 | 31.57 | 7.08 | 9.43 | 4.21 | 0.0 | - | ||
| 2022/4 | 1.36 | 12.96 | 25.53 | 5.45 | 4.17 | 3.86 | 0.0 | - | ||
| 2022/3 | 1.21 | -5.79 | -1.12 | 4.08 | -1.42 | 4.08 | 0.0 | - | ||
| 2022/2 | 1.28 | -19.51 | -27.5 | 2.88 | -1.55 | 4.09 | 0.0 | - | ||
| 2022/1 | 1.59 | 31.75 | 38.26 | 1.59 | 38.26 | 4.37 | 0.0 | - | ||
| 2021/12 | 1.21 | -22.62 | -19.94 | 16.96 | 9.37 | 3.92 | 0.0 | - | ||
| 2021/11 | 1.56 | 36.07 | 19.46 | 15.75 | 12.54 | 4.09 | 0.0 | - | ||
| 2021/10 | 1.15 | -16.85 | 38.06 | 14.18 | 11.82 | 4.06 | 0.0 | - | ||
| 2021/9 | 1.38 | -9.89 | 16.84 | 13.03 | 9.98 | 4.72 | 0.0 | - | ||
| 2021/8 | 1.53 | -15.02 | 22.66 | 11.65 | 9.22 | 5.18 | 0.0 | - | ||
| 2021/7 | 1.8 | -2.07 | 45.28 | 10.12 | 7.44 | 4.89 | 0.0 | - | ||
| 2021/6 | 1.84 | 48.37 | 44.34 | 8.32 | 1.69 | 4.17 | 0.0 | - | ||
| 2021/5 | 1.24 | 14.23 | -13.47 | 6.47 | -6.19 | 3.55 | 0.0 | - | ||
| 2021/4 | 1.09 | -11.02 | -33.57 | 5.23 | -4.28 | 4.08 | 0.0 | - | ||
| 2021/3 | 1.22 | -30.92 | -22.25 | 4.14 | 8.24 | 4.14 | 0.0 | - | ||
| 2021/2 | 1.77 | 53.48 | 34.97 | 2.92 | 29.5 | 4.43 | 0.0 | - | ||
| 2021/1 | 1.15 | -23.71 | 21.91 | 1.15 | 21.91 | 3.97 | 0.0 | - | ||
| 2020/12 | 1.51 | 15.46 | 24.16 | 15.5 | 35.09 | 3.65 | 0.0 | - | ||
| 2020/11 | 1.31 | 57.25 | 70.74 | 13.99 | 36.39 | 3.32 | 0.0 | 專案營收增加 | ||
| 2020/10 | 0.83 | -29.63 | -26.99 | 12.68 | 33.61 | 3.26 | 0.0 | - | ||
| 2020/9 | 1.18 | -5.4 | -10.09 | 11.85 | 41.88 | 3.67 | 0.0 | - | ||
| 2020/8 | 1.25 | 0.64 | 12.3 | 10.67 | 51.6 | 3.77 | 0.0 | 新產品上市營收持續注入，所以較去年累計營收大幅成長 | ||
| 2020/7 | 1.24 | -2.7 | 70.13 | 9.42 | 58.98 | 3.95 | 0.0 | 新產品上市營收持續注入，所以較去年同期及累計營收大幅成長 | ||
| 2020/6 | 1.28 | -11.06 | 46.55 | 8.18 | 57.42 | 4.35 | 0.0 | 新產品上市營收持續注入，所以較去年累計營收大幅成長。 | ||
| 2020/5 | 1.44 | -12.3 | 85.83 | 6.9 | 59.61 | 4.64 | 0.0 | 新產品上市營收注入，所以較去年同期營收大幅成長。 | ||
| 2020/4 | 1.64 | 4.14 | 105.49 | 5.46 | 53.9 | 4.52 | 0.0 | 新產品上市營收持續注入，所以較去年同期營收大幅成長。 | ||
| 2020/3 | 1.57 | 19.92 | 64.4 | 3.83 | 38.98 | 3.83 | 0.0 | 新產品上市營收持續注入，所以較去年同期營收大幅成長。 | ||
| 2020/2 | 1.31 | 38.64 | 46.91 | 2.26 | 25.47 | 3.47 | 0.0 | - | ||
| 2020/1 | 0.95 | -22.3 | 4.35 | 0.95 | 4.35 | 0.0 | N/A | - | ||
| 2019/12 | 1.22 | 58.77 | 60.53 | 11.47 | 1.22 | 0.0 | N/A | 1、參與資訊月活動收入提增。2、認列授權簽約金。 |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 1.3 | 2023/1 | 1.51 | 2022/1 | 1.59 | 2021/1 | 1.15 | 2020/1 | 0.95 |
| 2024/2 | 1.5 | 2023/2 | 1.2 | 2022/2 | 1.28 | 2021/2 | 1.77 | 2020/2 | 1.31 |
| 2024/3 | 1.02 | 2023/3 | 1.1 | 2022/3 | 1.21 | 2021/3 | 1.22 | 2020/3 | 1.57 |
| 2024/4 | 0.99 | 2023/4 | 1.11 | 2022/4 | 1.36 | 2021/4 | 1.09 | 2020/4 | 1.64 |
| 2024/5 | 1.02 | 2023/5 | 1.04 | 2022/5 | 1.63 | 2021/5 | 1.24 | 2020/5 | 1.44 |
| 2024/6 | 1.15 | 2023/6 | 0.98 | 2022/6 | 1.27 | 2021/6 | 1.84 | 2020/6 | 1.28 |
| 2024/7 | 1.05 | 2023/7 | 0.94 | 2022/7 | 1.24 | 2021/7 | 1.8 | 2020/7 | 1.24 |
| 2024/8 | 0.98 | 2023/8 | 1.01 | 2022/8 | 1.25 | 2021/8 | 1.53 | 2020/8 | 1.25 |
| 2024/9 | 1.13 | 2023/9 | 0.99 | 2022/9 | 1.32 | 2021/9 | 1.38 | 2020/9 | 1.18 |
| 2024/10 | 1.03 | 2023/10 | 1.16 | 2022/10 | 1.19 | 2021/10 | 1.15 | 2020/10 | 0.83 |
| 2024/11 | 1.45 | 2023/11 | 1.3 | 2022/11 | 1.25 | 2021/11 | 1.56 | 2020/11 | 1.31 |
| N/A | N/A | 2023/12 | 1.34 | 2022/12 | 1.23 | 2021/12 | 1.21 | 2020/12 | 1.51 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
